Search
Search
#1. Myeloma News
Multiple Myeloma News. ... ASH 2021: Making Sense of Newest Breakthroughs - Meet Vicki Jones · MYELOMA NEWS - December 06, 2021. After her diagnosis in 2004 ...
#2. Multiple Myeloma News - Cancer Therapy Advisor
KRd Plus ASCT Outperforms Other Carfilzomib-Based Regimens in Newly Diagnosed Multiple Myeloma. Publish Date November 30, 2021. Progression-free survival was ...
Gracell Biotechnologies' investigational new treatment for multiple myeloma, GC012F, has been named an orphan drug by the U.S. Food and Drug Administration (FDA) ...
#4. Myeloma Minute
Do you want to receive the latest myeloma news and research for free, ... with up-to-the 'minute' information about multiple myeloma.
#5. Day 2 Highlights from the 2021 International Myeloma Workshop
Several clinical trials of Abecma are ongoing. ... who had been exposed to a median of 8 prior treatments (87% were triple-class refractory, ...
#6. Myeloma - Latest research and news | Nature
02 December 2021 | Open Access ... Relapsed/refractory multiple myeloma (RRMM) is characterized by a remarkable heterogeneity and high ... News and Comment.
#7. Multiple Myeloma News, Articles and Research
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. ... Latest Multiple Myeloma News and Research ... 29 Nov 2021 ...
#8. News - Multiple Myeloma New Zealand
November 29, 2021News ... COVID mortality rate a concern in vaccinated blood cancer patients ... New Trial In Relapsed/refractory multiple myeloma.
#9. Multiple Myeloma News - ScienceDaily
Feb. 1, 2021 — Restoring an enzyme that maintains the way chromosomes are packed inside cells may lead to new therapies for some blood cancers, according to a ...
#10. Multiple Myeloma News - Index - Medscape
Multiple Myeloma News. ASH 2021 ASH Meeting: Diversity, Inclusion, Immunotherapy, and COVID-19 The American Society for Hematology 2021 Annual Meeting will ...
#11. Myeloma | JAMA Network
March 29, 2021. This economic evaluation assesses the optimal sequence of treatments for transplant-ineligible patients with multiple myeloma from the ...
#12. Research aims to address clinical challenges of triple-class ...
“Triple-class refractory multiple myeloma is kind of the all-equalizer because ... FDA-approved treatments include traditional chemotherapy, ...
#13. Myeloma | Oncology & Cancer News - Cure Today
The FDA approved the three-drug regimen of Darzalex Faspro, Kyprolis and dexamethasone for patients with pretreated relapsed/refractory multiple myeloma. Three- ...
#14. Therapy for Multiple Myeloma Has New Approach With One ...
Patients being treated for multiple myeloma have a promising new option for treatment. The treatment, called ABECMA, was recently approved ...
#15. New therapy shows promise in future treatment of multiple ...
A preclinical study has found multiple myeloma is highly sensitive to a newly ... by catalytic P300/CBP inhibition, Molecular Cell (2021).
#16. Multiple Myeloma | Clinical Oncology News | OncLive
Therapeutic Frontiers Expand for Patients With Relapsed/Refractory Multiple Myeloma. December 6th 2021. Various immune strategies have been developed in ...
#17. FDA Approves Ninlaro, New Oral Medication to Treat Multiple ...
FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma. Web Exclusives - FDA Approvals, In the News, Select Drug Profiles. Today the U.S. Food and ...
#18. Multiple Myeloma - Fred Hutchinson Cancer Research Center
Fred Hutch is at the forefront of developing treatments for multiple myeloma. Our researchers pioneered bone marrow transplantation, one of the most ...
#19. FDA approves promising treatment for multiple myeloma ...
Published: July 21, 2021 8:35 am. Tags: health. FDA approves promising treatment for multiple myeloma patients. The words 'Multiple Myeloma' ...
#20. Breakthroughs in Therapeutic Options for Relapsed/Refractory ...
Multiple Myeloma 2021 - Episode 1. Breakthroughs in Therapeutic Options for Relapsed/Refractory Multiple Myeloma. December 6, 2021.
#21. News & Stories - Myeloma UK
News Story 09 November 2021. Myeloma patient backs 20 for 20 campaign to help support people living with rare cancers. Read more.
#22. Multiple myeloma relapse: Signs, diagnosis, and outlook
People with multiple myeloma, which is a type of blood cancer, ... DNP, AOCNP, Nursing, Oncology — Written by Beth Sissons on November 24, 2021.
#23. Scientists Identify New Types of a Blood Cancer and Potential ...
Scientists Identify New Types of a Blood Cancer and Potential Targeted Treatments · Researchers are first to create a novel model for multiple ...
#24. Multiple Myeloma: Types of Treatment | Cancer.Net
Monoclonal antibodies (updated 12/2021). Elotuzumab (Empliciti) and daratumumab (Darzalex) are monoclonal antibodies that bind to myeloma cells and label them ...
#25. Myeloma Canada News
Latest news Updates on ASCO and EHA 2021 Conference Patients with light chain (AL) amyloidosis: La... Read more. — Monday, July 12, 2021. Health eMatters ...
#26. Multiple Myeloma Treatments, the Pharmacist's Role in Patient ...
Melphalan flufenamide (Pepaxto) was approved by the FDA on February 26, 2021, in combination with dexamethasone to treat adult patients with ...
#27. KCE Trials 2021 commissioned call on Multiple Myeloma
Background This call closed on 9th September 2021 Many questions in healthcare are currently not sufficiently studied in clinical trials, ...
#28. CAR-T Cell Therapy - Advances in The Management of ...
FDA Approves CAR T-cell therapy for multiple myeloma, ASH 2021 ... Patients who fail these approaches are in need of better treatments.
#29. What Is Multiple Myeloma Cancer and Is It Curable?
Oct. 18, 2021. Colin L. Powell, the first Black secretary of state, had multiple myeloma: a form of blood cancer that hobbles the immune ...
#30. Numerous Regimens Proposed for Relapsed or Refractory ...
Although patients with multiple myeloma can respond to initial ... of relapsed or refractory multiple myeloma during the 2021 National ...
#31. What's new in drug therapy - UpToDate
Anti-BCMA CAR-T cell therapy in multiple myeloma (March 2021, ... https://www.pfizer.com/news/press-release/press-release-detail/pfizers- ...
#32. Multiple Myeloma - ICER
ICER's analysis on the comparative clinical effectiveness and value of treatments for multiple myeloma. Learn more. ... Date of review: April 2021.
#33. Treatment: Multiple Myeloma - NHS
Chemotherapy medicines kill the myeloma cells. A number of treatments are often combined to treat multiple myeloma. These treatments are often taken in ...
#34. CAR T-Cell Therapy Approved for Multiple Myeloma - National ...
April 14, 2021 , by NCI Staff ... Although there are many treatments for multiple myeloma, they typically work for only a few months and can ...
#35. Costa Breaks Down Treatment Options for Patients With ...
... fatigue on exertion and was later diagnoses with multiple myeloma. ... Case-Based Roundtable Meeting Spotlight November 2, 2021,.
#36. Treatments for multiple myeloma | Canadian Cancer Society
Treatments for multiple myeloma include targeted therapy, chemotherapy and stem cell transplant. Learn more about treatment plans and options for multiple ...
#37. MyeNews - Myeloma Australia
MyeNews. Autumn 2021 Issue no 57 ... The great news, just after Christmas, was that daratumumab ... Now here's the thing with multiple myeloma, it affects.
#38. Myeloma - Oncology News Australia
EHA 2021: Daratumumab maintenance improves progression-free survival after autologous stem cell transplantation in multiple myeloma patients ... Part 1 of the ...
#39. Multiple Myeloma | ESMO
Multiple myeloma : EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Published in 2021 – Ann Oncol (2021)
#40. FDA Approves First Cell-Based Gene Therapy for Adult ...
FDA News Release ... For Immediate Release: March 27, 2021 ... “While there is no cure for multiple myeloma, the long-term outlook can vary ...
#41. Survival Rates by Stage for Multiple Myeloma - American ...
People now being diagnosed with myeloma may have a better outlook than these numbers show. Treatments have improved over time, and these numbers ...
#42. Investigating the Incurable: Spotlight on Multiple Myeloma ...
July 22, 2021. For individuals with multiple myeloma, even successful treatment can be difficult to celebrate: The blood cancer is notorious for relapse ...
#43. Multiple Myeloma Clinical Studies & News | Univadis
Patients with multiple sclerosis show robust T-cell response to mRNA COVID-19 vaccines. 21 September 2021. HIV/Infectious Diseases · Multiple Myeloma.
#44. ASCO 2021: Abstract Recommendations From Dr. Rafael ...
This study was designed to assess the clinical value of minimal residual disease (MRD) in the peripheral blood of patients with multiple myeloma ...
#45. Bristol Myers Squibb Receives European Commission ...
... the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma. 08/19/2021. Category: Corporate/Financial News.
#46. AbbVie acquires TeneoOne to keep pace in chase for new ...
Post a comment / Jun 24, 2021 at 4:34 PM. 1Shares ... Multiple myeloma, a cancer of the plasma cells, leads to tumors forming in the bones of the body.
#47. Efficacy and Safety Study of bb2121 in Subjects With ...
Genetic and Rare Diseases Information Center resources: Multiple Myeloma ... toxicities due to prior treatments, excluding alopecia and Grade 2 neuropathy.
#48. FDA Issues Warning About Multiple Myeloma Treatment ...
Pharmacy Practice News (PPN) strives to provide health-system pharmacists with accurate, relevant and up-to-date information that improves their ...
#49. CAR T-cell therapy generates lasting remissions in patients with
In a major advance in the treatment of multiple myeloma, ... A decision on the application is expected by the end of March 2021.
#50. Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA ...
Accessed January 2021. 5 Mikhael, J, Ismaila N, Cheung M, et al. Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline.
#51. Leukemia & Lymphoma Society | Blood Cancer Leaders | LLS
The Leukemia & Lymphoma Society has been the largest nonprofit funder of blood cancer research since 1949. Visit us to learn more about how you can help.
#52. Novel immunotherapy shows robust response for multiple ...
10, 2021, 8:38 AM ... BCMA is universally expressed in multiple myeloma with minimal expression on normal tissue, which makes it an ideal ...
#53. A new era of novel immunotherapies for multiple myeloma
11. van de Donk NWCJ; Usmani SZ; Yong K. CAR T-cell therapy for multiple myeloma: state of the art and prospects. Lancet Haematol. 2021 ...
#54. Clinical Trials Gave Wilmot Multiple Myeloma Patient 18 Years
But multiple myeloma survivor Alan Brandon is living proof ... “I received treatments where other people proved that the drugs were ...
#55. Multiple Myeloma Awareness Month: 2021 Immunotherapy ...
We look at new research, new treatments, and how we're working toward a future immune to multiple myeloma.
#56. EHA 2021: Overall survival benefit established with ... - ecancer
... newly diagnosed multiple myeloma. 12 Jun 2021. EHA 2021: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone in ...
#57. Multiple Myeloma Epidemiology Forecast Report 2021-2030
Multiple Myeloma Epidemiology Forecast Report 2021-2030 ... July 06, 2021 03:48 AM Eastern Daylight Time ... More News RSS feed for null.
#58. Renal Insufficiency May Worsen Multiple Myeloma Outcomes
22, 2021 (HealthDay News) -- For patients with multiple myeloma (MM), those with renal insufficiency (RI) have an increased risk for disease ...
#59. First cell-based gene therapy to treat adult patients with ...
... to treat adult patients with multiple myeloma. News 25/06/2021 ... Multiple myeloma is a rare cancer of a type of white blood cell called plasma cells.
#60. Global Multiple Myeloma Drugs Market (2021 to 2026) -
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and ...
#61. Four Drugs Upfront Yield 'Unprecedented' Response in ...
Adding the anti-CD38 drug daratumumab (Darzalex) to a weekly three-drug regimen for patients with newly diagnosed multiple myeloma led to ...
#62. Management of patients with multiple myeloma beyond the ...
Treatment options in multiple myeloma (MM) are increasing with the introduction ... Blood Cancer J. 2021 Feb 18;11(2):40. doi: 10.1038/s41408-021-00432-4.
#63. Global Multiple Myeloma Disease Coverage Forecast and ...
Global Multiple Myeloma Disease Coverage Forecast and Market Analysis 2021-2027: Key Upcoming Events for 2021 Include the Expected US ...
#64. Emerging therapies for relapsed/refractory multiple myeloma
Melphalan flufenamide combined with dexamethasone was approved by the FDA in February 2021 based on HORIZON trial (NCT02963493) in RRMM patients ...
#65. GSK showcases progress from the DREAMM clinical trial ...
18, 2021 /PRNewswire/ -- GlaxoSmithKline (GSK) plc today announced ... As part of GSK's ongoing commitment to the multiple myeloma community ...
#66. 18 Terrible, Wonderful Years: A Multiple Myeloma Patient ...
Cancer survivor Dan Bammes was diagnosed with multiple myeloma in 2003. ... Mar 08, 2021 2:00 PM. Read Time: 4 minutes. Author: Dan Bammes.
#67. Janssen's teclistamab offers durable responses in multiple ...
... Phase I MajesTEC-1 study, where teclistamab provided durable responses in multiple myeloma patients. ... 25 May 2021 (Last Updated May 25th, 2021 17:37).
#68. Multiple Myeloma Archives - ASH Clinical News
ASH Clinical News. ... features and news articles published in ASH Clinical News related to multiple myeloma. ... Multiple Myeloma Monday, November 1, 2021 ...
#69. Mayo Clinic researchers study new class of drugs to treat ...
June 14, 2021. Bone marrow aspirate cytology of multiple myeloma ... A paper highlighting this work was published in Blood Cancer Discovery.
#70. How I Treat High-risk Multiple Myeloma | Blood - ASH ...
Survival of multiple myeloma (MM) has significantly improved over the last decade; however, a composed group of ... Research Article| November 2, 2021 ...
#71. Induction Therapy for Newly Diagnosed Multiple Myeloma
Induction treatments for patients with MM have traditionally relied on a backbone of a combinations of immunomodulatory imide drugs (IMiDs), proteasome ...
#72. Regina woman marches to create awareness about myeloma ...
Patti Schmidt was diagnosed with multiple myeloma - also known as myeloma ... myeloma survivor helps to raise money for cure – Sep 12, 2021.
#73. iwMyeloma 2021
Session 1: Drug Resistance and High-Risk Multiple Myeloma · Session 2: Management of Older Patients and Smoldering Multiple Myeloma · Session 3: The Clinical ...
#74. Understanding multiple myeloma - News4Jax
Understanding multiple myeloma ... Watch News4Jax at 11 p.m. : Dec 06, 2021 · Watch The 10 O'Clock News : Dec 06, 2021 ...
#75. UCSF at the Forefront of New Therapies, Giving Hope to ...
... advances in the treatment of multiple myeloma (MM) have ... July 15, 2021 ... helping to bring these treatments into clinical practice.
#76. Older Multiple Myeloma Patients can be Spared of Long-Term ...
(WASHINGTON, March 19, 2021) — The combination of cancer therapy lenalidomide plus the steroid dexamethasone (together called Rd) is considered ...
#77. CAR T Cell Therapy Offers New Hope for Multiple Myeloma
MSK researchers are optimistic about this BCMA-focused CAR T strategy. In March 2021, the FDA approved a CAR T cell treatment that targets BCMA ...
#78. Vaccines less protective for multiple myeloma patients - Reuters
Claims of stem cell treatments for COVID-19 are bogus.
#79. New drug target for multiple myeloma - British Society for ...
TAK1-inhibitors reduce multiple myeloma cell viability and induce ... KK (2021) “TAK1-inhibitors are cytotoxic for multiple myeloma cells ...
#80. Will Blenrep Improve Myeloma Treatment Options in 2021?
Belantamab mafodotin (Blenrep) is an exciting new drug that has the potential to quickly change the treatment landscape of multiple myeloma. The ...
#81. Grant receives $200,000 to study Impact of Multiple Myeloma ...
Grant receives $200,000 to study Impact of Multiple Myeloma on Older Adult Patients, Care Partners. September 8, 2021.
#82. Perspectives in therapy of multiple myeloma, 2021 - Medical ...
The key trends in myeloma care in 2021 will enhance outcomes, but patients and doctors will face serious challenges in the aftermath of the ...
#83. Global Multiple Myeloma Treatment Drugs Market Industry ...
The MarketWatch News Department was not involved in the creation of this content. Oct 25, 2021 (AmericaNewsHour) -- Research Nester released ...
#84. New FDA approved drug for multiple myeloma - WSAW
In December, the FDA approved the drug XPOVIO® as the first new treatment option in five years for multiple myeloma patients who have ...
#85. One drop of blood brings progression of multiple myeloma into ...
26 March 2021. ... Multiple myeloma is a severe form of blood cancer. ... Improved treatments have made it possible to keep the disease ...
#86. Working group: More guidance needed on MRD in myeloma ...
Posted 19 August 2021 | By Mary Ellen Schneider ... Often, novel drugs are most likely to benefit [multiple myeloma] patients in early lines more than in ...
#87. Dana-Farber to present more than 30 research studies at ...
Scientific updates to be presented at 2021ASH Annual Meeting reveal potentially ... Multiple myeloma evolves from monoclonal gammopathy of ...
#88. Lenalidomide treatment 'massive change' for multiple ... - BBC
Around 6,000 people a year are diagnosed with multiple myeloma, ... the decision to make this available through the NHS is fantastic news.
#89. FDA Approves Darzalex Faspro Plus Kd for RR Multiple ...
This cohort enrolled 66 patients with relapsed or refractory multiple myeloma who received at least one prior line of therapy. In the trial, ...
#90. Triple therapy recommended by NICE for patients with ...
22 March 2021. A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma after NICE recommended its ...
#91. New cellular therapy offers hope for multiple myeloma patients
In March 2021, the FDA approved Abecma as the first cell-based gene therapy for patients with treatment-resistant multiple myeloma. It works by ...
#92. What's New in Multiple Myeloma Treatment - Cancer - WebMD
Several new drugs have been approved to treat multiple myeloma since 2015, including relapsed and refractory forms of the disease, says Lee.
#93. Novartis R&D day spotlights attractive growth profile ...
Basel, December 2, 2021 — Novartis today holds an investor event to ... 100% Best Overall Response (BOR) in multiple myeloma, respectively.
#94. Advances in Multiple Myeloma and Waldenstrom's ...
News ; Nov | 4 | 2021. COVID-19 Vaccine FAQs ...
#95. Idecabtagene Vicleucel in Relapsed and Refractory Multiple ...
Despite treatment advances in multiple myeloma, relapses are common. ... This article was updated on March 10, 2021, at NEJM.org.
#96. FDA-Approved Cell Therapy for Multiple Myeloma Now at Fox ...
While advanced treatments have emerged in recent years including chemotherapy, immunotherapy, and stem cell transplant, multiple myeloma ...
#97. Off-the-Shelf Immune Drug Shows Promise in Aggressive ...
... Multiple Myeloma. News Release ... “These are exciting results for multiple myeloma patients,” Garfall said. “To have a single, ...
#98. What All Myeloma Patients Need to Know in 2021 - YouTube
Dr. Brian GM Durie presents "What All Myeloma Patients Need to Know in 2021: From Myeloma 101 to Vaccines and Variants" during the IMF ...
#99. Myeloma patients can look forward to a targeted new ...
Greg Hunt MP, has announced multiple myeloma patients whose blood cancer has progressed after initial treatment will be able to access ...
multiple myeloma news 2021 在 What All Myeloma Patients Need to Know in 2021 - YouTube 的推薦與評價
Dr. Brian GM Durie presents "What All Myeloma Patients Need to Know in 2021: From Myeloma 101 to Vaccines and Variants" during the IMF ... ... <看更多>